Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells

W Peng1, J Chen, Y-H Huang

  • 1Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.

Gene Therapy
|July 22, 2005
PubMed

Insights

This study developed a dual gene control system using prostate-specific antigen (PSA) promoter regulation and Flp recombinase to target diphtheria toxin (DT-A) expression. This approach effectively reduced prostate tumor size and induced cancer cell death, showing promise for prostate cancer therapy.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • Gene expression control is crucial for targeted cancer therapies.
  • A dual system combining transcriptional regulation and DNA recombination offers enhanced control.
  • The prostate-specific antigen (PSA) promoter is a validated target for prostate cancer therapies.

Purpose of the Study:

  • To investigate a novel dual gene expression control system for targeted cancer therapy.
  • To evaluate the efficacy of a PSA promoter-driven Flp recombinase system regulating diphtheria toxin (DT-A) expression.
  • To assess the therapeutic potential of this system in prostate cancer models.

Main Methods:

  • Adenoviral delivery of DNA encoding PSA promoter-driven Flp recombinase and DT-A.
  • Utilized human prostate cancer cells in culture, xenografts, and TRAMP mouse models.
  • Monitored DT-A expression, tumor size reduction, and cell viability.

Main Results:

  • DT-A expression was effectively activated in a manner correlating with PSA and androgen levels.
  • Xenograft tumor size was reduced by 50% following treatment.
  • Intratumoral injection of DT-A viruses led to significant tumor cell death and prostate size reduction in mice.

Conclusions:

  • The PSA promoter-driven Flp recombinase system enables targeted death of PSA-expressing cells.
  • This approach holds promise for developing effective systemically-administered therapies for metastatic prostate cancer.
  • Further development combined with targeted gene delivery strategies could enhance therapeutic outcomes.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...